Texas compounder Greenwich Rx recalls sterile products nationwide over sterility assurance
The lots were dispensed nationwide between August 10, 2026 and September 21, 2026, and include some products made for another pharmacy, Clove Rx.
Key takeaways
- Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, announced a voluntary nationwide recall of specific lots of compounded sterile products on November 20, 2026.
- The company cited a potential lack of sterility assurance, a concern that arose after an FDA inspection and the company's own review of the products.
- The recalled products were dispensed nationwide between August 10, 2026 and September 21, 2026, and include some compounded for another pharmacy, Clove Rx.
- Greenwich Rx said it has found no evidence of contamination and has received no adverse event reports tied to the recall.
- For crews: the affected products, lot numbers and beyond-use dates are on the list Greenwich Rx posted at greenwichrx.org/news/general-recall-2026-11; the announcement itself does not name the drugs.
Greenwich Rx, a 503A compounding pharmacy based in Tomball, Texas, announced on November 20, 2026, that it is recalling specific lots of compounded sterile products nationwide. The company cited a "potential lack of sterility assurance," according to its announcement posted by the FDA [1]. The recall reaches the consumer level and covers lots that are still within their beyond-use dates [1].
The recall also covers some products that Greenwich Rx compounded for a second pharmacy, Clove Rx, the announcement said [1]. According to the company, the concerns came up after the FDA inspected the pharmacy and Greenwich Rx then evaluated the affected products [1].
Greenwich Rx said it has not found evidence of contamination in the recalled products and described the action as precautionary. The company also said it has not received any adverse event reports linked to the recall [1].
What the records show
The FDA page classifies the products as drugs. It lists the brand as Greenwich Rx and describes the products only as "compounded sterile products" [1]. The agency notes that it posts company recall announcements as a public service and does not endorse the company or the product [1].
- Distribution window: The affected products were dispensed nationwide between August 10, 2026 and September 21, 2026, according to the announcement [1].
- Product list: The announcement does not name individual drugs, strengths or lot numbers in its text. Instead it points to a list of products, lot numbers and beyond-use dates posted at greenwichrx.org/news/general-recall-2026-11 [1].
- Risk statement: The company wrote that using a drug meant to be sterile that is not sterile "could result in serious infections, which may be life threatening" [1].
- Notification: Greenwich Rx said it is notifying its affected customers by mail. People who got medications through Clove Rx are asked to check the product list even if no notice reaches them directly [1].
- Company instruction: The announcement tells consumers and clinics holding recalled product to "stop use of the product immediately and discard it," and refers readers to FDA.gov/DrugDisposal for disposal information [1].
- Questions: The company named Sedgwick to take recall questions at 888-243-5547 or GreenwichRx6588@sedgwick.com, Monday through Friday, 8:00 AM to 5:00 PM Eastern Time [1].
- Reporting: Adverse reactions or quality problems may be reported to the FDA's MedWatch program online, by mail or by fax, according to the announcement [1].
The company said the recall is being carried out with the knowledge of the FDA [1].
Why it matters for EMS
The announcement addresses clinics as well as individual consumers [1]. That means facility stock, not only home prescriptions, may include affected lots. The record does not say whether any EMS agencies, hospitals or other first-response services bought products from Greenwich Rx or Clove Rx.
The infection risk the company describes matters for patient assessment. A patient seen in the field may have used a compounded sterile product dispensed during the August-to-September window. The announcement asks anyone who has had problems possibly tied to the recalled drugs to contact a physician or healthcare provider [1]. The company says it has received no reports of adverse events so far [1].
Because the announcement does not list products by name, the only way to tell whether a given product is involved is to compare its label with the company's posted list [1]. EMS clinicians follow local protocols and medical direction on recalled medications.
What the records do not tell us
- The announcement does not name the drugs, dosage forms, routes of administration or number of lots involved.
- It does not say how many units were dispensed, how many customers were affected, or which states received product beyond the word "nationwide."
- The FDA inspection findings that led to the recall are not described in the packet, and the date of the inspection is not given.
- The records do not explain the business relationship between Greenwich Rx and Clove Rx, and they contain no statement from Clove Rx.
- The FDA page carries the company's announcement; it does not include a separate assessment from the agency.
What to watch
The announcement sets no follow-up date or deadline. The company's posted product list is the reference point for which lots are affected, and the records do not say whether that list will be updated [1].
Questions readers ask
Why is Greenwich Rx recalling compounded sterile products?
Greenwich Rx cited a potential lack of sterility assurance. The company said the concerns came up after an FDA inspection of the pharmacy and its own evaluation of the affected products.
Which Greenwich Rx products are included in the recall?
The announcement does not name the drugs in its text. It says a list of affected products, lot numbers and beyond-use dates is posted at greenwichrx.org/news/general-recall-2026-11.
Are Clove Rx medications part of the Greenwich Rx recall?
Some of them are. The recall includes products Greenwich Rx compounded for Clove Rx, and Clove Rx customers are asked to check the affected product list even if they get no direct notice.
Have any injuries been reported from the Greenwich Rx recall?
Greenwich Rx said it has not received any reports of adverse events related to the recall. It also said it has found no evidence of contamination in the recalled products.
Sources
- FDA: Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance (company announcement, November 20, 2026) — fda.gov (2026-11-20). fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenwich-rx-i
This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.


